Recital 20, Regulation (EU) 2025/2086

In forcesince 17 Oct 2025

To contribute to the completeness and high quality of the dossier and the smooth conduct of the joint clinical assessment, the health technology developer should be able to request an assessment scope explanation meeting with the JCA Subgroup.